The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
"An extraordinary number of people are taking opioids in one form or another," said Powell, during testimony before the House Financial Services Committee. "It weights on labor force participation, largely but not exclusively on younger males and younger women. It's a national crisis, really."
"The humanitarian aspect is completely compelling. But the economic impact is also quite substantial," Powell said.
The rate of labor force participation, which captures people working and those who want jobs, has steadily fallen since the Great Recession caused by the 2008 financial crisis, according to the U.S. Bureau of Labor Statistics, stagnating near 63% over the last five years.
Janet Yellen also addressed the opioid crisis impact on the economy during her time as Fed chair before Powell. In testimony before the Senate Banking Committee in 2017, Yellen said, in comments similar to Powell's, that rampant opioid abuse in the U.S. is related to the decline in labor force participation among prime-age workers.
Health policy experts generally agree with Powell and Yellen about the magnitude of the opioid crisis and how it's partly responsible for that decline in the labor participation rate.
More than 130 people in the U.S. die every day from opioid overdoses, with about 47,000 people dying in 2017, according to data from the Centers for Disease Control and Prevention. The proliferation of opioids is a major issue for U.S. lawmakers and the Trump administration, which have vowed to crack down on illicit use.
President Donald Trump on Wednesday morning addressed the epidemic during a speech from Washington, D.C.
"We're aggressively confronting the opioid, fentanyl and drug addiction epidemic," Trump said before signing his executive order to overhaul the nation's kidney care market. "We're making tremendous strides."
Earlier this year, a former CEO of Rochester Drug Cooperative, one of the nation's largest drug distributors, was indicted on what prosecutors say are the first criminal charges against an executive of a drug company to stem from the opioid epidemic. In addition, the federal government reached a $20 million settlement with the company over its alleged role in the crisis.
The federal charges came as OxyContin maker Purdue Pharma, who has been blamed for igniting the epidemic, faces some 1,600 lawsuits and possible bankruptcy. The Stamford, Connecticut-based company has been accused by nearly every U.S. state of downplaying how dangerously addictive its blockbuster painkiller is while exaggerating its benefits.